Pacs Group Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pacs Group Inc 's ROA in the third quarter of 2026?
Pacs Group Inc achieved a return on average assets (ROA) of 4.87 % in its third quarter of 2026 a new company high.

Despite the company's net income deteriorating, Pacs Group Inc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 152 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 1299, from total ROA ranking in the second quarter of 2026 at 1751.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	2.03 %	5.24 %	3.4 %	267.78 %	498.34 %
Y / Y Net Income Change	16.22 %	49.8 %	184.24 %	65.19 %	222.83 %
Net Income (TTM) in million	278	269	244	191	168
Return On Assets (TTM)	4.87 %	4.74 %	4.35 %	3.45 %	3.7 %
PACS's Total Ranking	# 1299	# 1751	# 1525	# 1637	# 2123
Total Assets (TTM) in million	5,741	5,791	5,682	5,602	5,627
Seq. Total Assets Change	-0.87 %	1.92 %	1.42 %	-0.43 %	2.25 %
Seq. Net Income Change	-20.34 %	-5.35 %	34.93 %	14.25 %	2.68 %

PACS's 5 Years Annual ROA >> Back to PACS Management Effectiveness >> Compare PACS ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 20
Sector	# 153
Overall	# 1203

Return On Assets Statistics
High	Average	Low
4.87 %	3.26 %	1.12 %
(Sep 30 2026)		(Mar 31 2025)

Financial Statements
Pacs Group Inc 's Assets	$ 5,741 million	PACS's Balance sheet
Pacs Group Inc 's Income	$ 61 million	Quarterly PACS's Income Statement
PACS's Income by Division		See PACS's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2022) FY 2024	FY	FY	FY
Y / Y Total Assets Change	267.78 %	-	-	-	-
Total Assets in million	5,602	1,523	0	0	0
Y / Y Net Income Change	27.22 %	-	-	-	-
Net Income in million	191	150	0	0	0
Annual Return On Assets	3.42 %	9.88 %	-	-	-

PACS's 5 Years Annual ROA >> Back to PACS Management Effectiveness >> Compare PACS ROA to its Competitors

Comment on PACS's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA deteriorated to 3.42 %, despite annual net income growth of 27.22 % to $191.46 million, from $150.50 million a year ago, as PACS's assets increase to $5,602.44 million, by 27.22 %.

More Return On Assets Ratios
PACS's' Return on Assets at Yahoo Finance
Healthcare Facilities Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PACS's Roa Ratio versus Healthcare Facilities Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PACS's Competitors
Subscribers only: Roa for Pacs Group Inc 's Suppliers
Subscribers only: Return On Assets for PACS's Customers

You may also want to know
PACS's Roi	PACS's Inventory Turnover Ratio	PACS's Growth Rates	PACS's Dividend Comparisons
	PACS's Profitability Ratios	PACS's Asset Turnover Ratio	PACS's Dividend Growth
PACS's Roe	PACS's Valuation Ratios	PACS's Financial Strength Ratios	PACS's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %
Medinotec Inc	8.67 %
Tactile Systems Technology Inc	8.53 %
Penumbra Inc	8.13 %
Johnson and Johnson	8.06 %
Pacific Health Care Organization Inc	7.83 %
Boston Scientific Corporation	7.82 %
Ani Pharmaceuticals Inc	7.77 %
Stryker Corp	7.66 %
Abbvie Inc	7.48 %
Ensign Group Inc	7.00 %
Pediatrix Medical Group Inc	6.99 %
Quest Diagnostics Inc	6.96 %
Davita Inc	6.65 %
Brightspring Health Services Inc	6.60 %

Date modified: 2026-11-04T15:23:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.